Skip Navigation


Rheumatology Advance Access originally published online on August 16, 2005
Rheumatology 2005 44(10):1322-1323; doi:10.1093/rheumatology/kei026
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
44/10/1322    most recent
kei026v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Yamamoto, M.
Right arrow Articles by Imai, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamamoto, M.
Right arrow Articles by Imai, K.
Related Collections
Right arrow Sjogren's Syndrome
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org

LETTER TO THE EDITOR

Beneficial effects of steroid therapy for Mikulicz's disease

M. Yamamoto, S. Harada, M. Ohara, C. Suzuki, Y. Naishiro, H. Yamamoto, H. Takahashi, Y. Shinomura and K. Imai1

First Department of Internal Medicine, Sapporo Medical University, School of Medicine and 1 Sapporo Medical University, Sapporo, Hokkaido, Japan

Correspondence to: M. Yamamoto, First Department of Internal Medicine, Sapporo Medical University, School of Medicine, South 1-West 16, Chuo-ku, Sapporo, Hokkaido, Japan. E-mail: mocha@cocoa.plala.or.jp

The first 10% of the full text of this article appears below.

SIR, Mikulicz's disease (MD) represents a unique condition involving symmetrical enlargement of the lacrimal and salivary glands, the cause of which is unknown. It has been included within the diagnostic criteria for primary Sjögren's syndrome (SS) due to their histological resemblance [1]. However, it is clear that the pathogenesis of MD differs from that of SS because an elevated serum IgG4 concentration and infiltration of abundant plasmacytes with IgG4 into . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Rheumatology (Oxford)Home page
M. Yamamoto, H. Takahashi, K. Hasebe, C. Suzuki, Y. Naishiro, T. Hayashi, H. Yamamoto, T. Ishida, and Y. Shinomura
The analysis of interleukin-6 in patients with systemic IgG4-related plasmacytic syndrome--expansion of SIPS to the territory of Castleman's disease
Rheumatology, July 1, 2009; 48(7): 860 - 862.
[Full Text] [PDF]